Bosmana fem at 17:58, 2 April 2023

2023-04-02T17:58:11Z

← Older revision		Revision as of 17:58, 2 April 2023
Line 1:		Line 1:
			=Introduction to Cost-effectiveness=

			==Defining Cost-effectiveness==
			Cost-effectiveness analysis (CEA) is a vital tool in public health epidemiology. It provides a framework for evaluating the relative value of different health interventions by comparing the costs and outcomes of each option. In other words, CEA assesses the efficiency of public health programs or policies by determining the best allocation of limited resources to maximize health gains. This approach is particularly essential in public health, where resources are often scarce, and decision-makers must allocate them wisely to address pressing health concerns.

			==Components of Cost-effectiveness Analysis==
			A typical CEA consists of two main components: costs and outcomes. Costs refer to the monetary value of resources used in implementing an intervention, such as labour, equipment, and supplies. Outcomes are the health benefits the intervention achieves, often measured in natural units (e.g., cases averted) or preference-based units (e.g., quality-adjusted life years or QALYs).

			==Cost-effectiveness Ratio==
			The cost-effectiveness ratio (CER) is a key metric for comparing interventions. It is calculated by dividing the difference in costs between two interventions by the difference in their outcomes. A lower CER indicates a more cost-effective intervention. Decision-makers can use CERs to rank interventions and prioritize those that offer the greatest value for money.

			=Conducting a Cost-effectiveness Analysis=
			==Identifying Interventions and Comparator(s)==
			The first step in conducting a CEA is identifying the interventions to evaluate and the appropriate comparator(s). The comparator can be the current standard of care, no intervention, or other relevant alternatives. Comparing interventions to relevant alternatives is crucial in determining the incremental cost-effectiveness of an intervention.

			==Measuring Costs and Outcomes==
			Next, the costs and outcomes of each intervention must be measured. Costs should be assessed from a societal perspective, considering all relevant direct and indirect costs. These may include medical costs, patient time and travel costs, and productivity losses due to illness. Outcomes should be measured regarding health gains, such as cases prevented or QALYs gained.

			==Discounting and Time Horizon==
			CEA typically involves estimating costs and outcomes over an extended period, necessitating discounting to account for the time value of money. Discounting adjusts future costs and outcomes to present value, reflecting the preference for benefits to be realized sooner rather than later. The choice of discount rate and time horizon can significantly impact the results of the analysis.

			==Sensitivity Analysis==
			Uncertainty is inherent in CEA, arising from factors such as data limitations, variability in cost and outcome estimates, and the choice of model parameters. Sensitivity analysis tests the robustness of CEA results by varying key assumptions and inputs. This helps to identify influential factors and quantify the uncertainty surrounding the cost-effectiveness estimates.

			=Applying Cost-effectiveness in Public Health Decision-making=
			==Prioritizing Interventions==
			CEA can inform public health decision-making by identifying and prioritizing cost-effective interventions. Decision-makers can allocate resources to interventions with lower CERs, maximizing health gains under budget constraints. However, other factors, such as equity, feasibility, and acceptability, should also be considered when allocating resources.

			==Limitations and Ethical Considerations==
			While CEA is a valuable tool in public health epidemiology, it has limitations. Results can be sensitive to methodological choices, such as the selection of outcomes, discount rates, and model assumptions. Furthermore, CEA primarily focuses on economic efficiency and may overlook important societal values, such as equity, fairness, and cultural acceptability. These concerns highlight the need for decision-makers to complement CEA findings with a broader range of qualitative and quantitative information, ensuring that resource allocation decisions are economically efficient, ethically sound, and socially responsible.


			=References=
			* This text was written by ChatGPT4.0 on 2 April 2023 and edited by Arnold Bosman
			* Culyer, A. J., & Newhouse, J. P. (Eds.). (2000). Handbook of Health Economics (Vol. 1). Elsevier.



	[[Category:Health Economics]]		[[Category:Health Economics]]

Bosmana fem: Created page with " Category:Health Economics"

2023-03-22T22:22:40Z

Created page with " Category:Health Economics"

New page

[[Category:Health Economics]]

Cost-effectiveness - Revision history

Bosmana fem at 17:58, 2 April 2023

Bosmana fem: Created page with " Category:Health Economics"